Literature DB >> 26633691

Functional Status, Quality of Life, and Costs Associated With Fibromyalgia Subgroups: A Latent Profile Analysis.

Juan V Luciano1, Carlos G Forero, Marta Cerdà-Lafont, María Teresa Peñarrubia-María, Rita Fernández-Vergel, Antonio I Cuesta-Vargas, José M Ruíz, Antoni Rozadilla-Sacanell, Elena Sirvent-Alierta, Pilar Santo-Panero, Javier García-Campayo, Antoni Serrano-Blanco, Adrián Pérez-Aranda, María Rubio-Valera.   

Abstract

OBJECTIVES: Although fibromyalgia syndrome (FM) is considered a heterogeneous condition, there is no generally accepted subgroup typology. We used hierarchical cluster analysis and latent profile analysis to replicate Giesecke's classification in Spanish FM patients. The second aim was to examine whether the subgroups differed in sociodemographic characteristics, functional status, quality of life, and in direct and indirect costs.
MATERIALS AND METHODS: A total of 160 FM patients completed the following measures for cluster derivation: the Center for Epidemiological Studies-Depression Scale, the Trait Anxiety Inventory, the Pain Catastrophizing Scale, and the Control over Pain subscale. Pain threshold was measured with a sphygmomanometer. In addition, the Fibromyalgia Impact Questionnaire-Revised, the EuroQoL-5D-3L, and the Client Service Receipt Inventory were administered for cluster validation.
RESULTS: Two distinct clusters were identified using hierarchical cluster analysis ("hypersensitive" group, 69.8% and "functional" group, 30.2%). In contrast, the latent profile analysis goodness-of-fit indices supported the existence of 3 FM patient profiles: (1) a "functional" profile (28.1%) defined as moderate tenderness, distress, and pain catastrophizing; (2) a "dysfunctional" profile (45.6%) defined by elevated tenderness, distress, and pain catastrophizing; and (3) a "highly dysfunctional and distressed" profile (26.3%) characterized by elevated tenderness and extremely high distress and catastrophizing. We did not find significant differences in sociodemographic characteristics between the 2 clusters or among the 3 profiles. The functional profile was associated with less impairment, greater quality of life, and lower health care costs. DISCUSSION: We identified 3 distinct profiles which accounted for the heterogeneity of FM patients. Our findings might help to design tailored interventions for FM patients.

Entities:  

Mesh:

Year:  2016        PMID: 26633691     DOI: 10.1097/AJP.0000000000000336

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  12 in total

1.  Diagnostic difficulty, delayed diagnosis, and increased tendencies of surgical treatment in fibromyalgia syndrome.

Authors:  Sevinç Külekçioğlu
Journal:  Clin Rheumatol       Date:  2021-10-21       Impact factor: 2.980

2.  Cognitive behavioral therapy with and without biofeedback in fibromyalgia: Assessment of functional and clinical change.

Authors:  Leila Govillard; Susana Gorbeña; Ioseba Iraurgi
Journal:  Health Psychol Open       Date:  2022-06-17

3.  Somatic symptom presentations in women with fibromyalgia are differentially associated with elevated depression and anxiety.

Authors:  Katherine Hadlandsmyth; Dana L Dailey; Barbara A Rakel; M Bridget Zimmerman; Carol Gt Vance; Ericka N Merriwether; Ruth L Chimenti; Katharine M Geasland; Leslie J Crofford; Kathleen A Sluka
Journal:  J Health Psychol       Date:  2017-10-27

4.  Long-term outcomes of adolescents with juvenile-onset fibromyalgia into adulthood and impact of depressive symptoms on functioning over time.

Authors:  Susmita Kashikar-Zuck; Natoshia Cunningham; James Peugh; William R Black; Sarah Nelson; Anne M Lynch-Jordan; Megan Pfeiffer; Susan T Tran; Tracy V Ting; Lesley M Arnold; Adam Carle; Jennie Noll; Scott W Powers; Daniel J Lovell
Journal:  Pain       Date:  2019-02       Impact factor: 7.926

5.  Impact of IPDE-SQ personality disorders on the healthcare and societal costs of fibromyalgia patients: a cross-sectional study.

Authors:  Laura Gumà-Uriel; M Teresa Peñarrubia-María; Marta Cerdà-Lafont; Oriol Cunillera-Puertolas; Jesús Almeda-Ortega; Rita Fernández-Vergel; Javier García-Campayo; Juan V Luciano
Journal:  BMC Fam Pract       Date:  2016-06-01       Impact factor: 2.497

6.  Psychometric Properties of the Cognitive Emotion Regulation Questionnaire (CERQ) in Patients with Fibromyalgia Syndrome.

Authors:  Albert Feliu-Soler; Elvira Reche-Camba; Xavier Borràs; Adrián Pérez-Aranda; Laura Andrés-Rodríguez; María T Peñarrubia-María; Mayte Navarro-Gil; Javier García-Campayo; Juan A Bellón; Juan V Luciano
Journal:  Front Psychol       Date:  2017-12-13

Review 7.  A Brief Review of the Pharmacology of Amitriptyline and Clinical Outcomes in Treating Fibromyalgia.

Authors:  Kim Lawson
Journal:  Biomedicines       Date:  2017-05-17

8.  Suicidal Ideation Profiles in Patients with Fibromyalgia Using Transdiagnostic Psychological and Fibromyalgia-Associated Variables.

Authors:  Jorge L Ordóñez-Carrasco; María Sánchez-Castelló; Elena P Calandre; Isabel Cuadrado-Guirado; Antonio J Rojas-Tejada
Journal:  Int J Environ Res Public Health       Date:  2020-12-30       Impact factor: 3.390

9.  Clustering fibromyalgia patients: A combination of psychosocial and somatic factors leads to resilient coping in a subgroup of fibromyalgia patients.

Authors:  Alexandra Braun; Dimitar Evdokimov; Johanna Frank; Paul Pauli; Nurcan Üçeyler; Claudia Sommer
Journal:  PLoS One       Date:  2020-12-28       Impact factor: 3.240

10.  Saffron (Crocus sativus) versus duloxetine for treatment of patients with fibromyalgia: A randomized double-blind clinical trial.

Authors:  Mansoor Shakiba; Ehsan Moazen-Zadeh; Ahmad Ali Noorbala; Morteza Jafarinia; Parisa Divsalar; Ladan Kashani; Nazila Shahmansouri; Abbas Tafakhori; Hannaneh Bayat; Shahin Akhondzadeh
Journal:  Avicenna J Phytomed       Date:  2018 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.